Newron Pharmaceuticals S.p.A. (SWX:NWRN)
17.70
-0.10 (-0.56%)
At close: Nov 28, 2025
Revenue by Product
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.